Prospective study of efficacy and safety of preoperative transcatheter arterial chemolipiodolization with miriplatin for hepatocellular carcinoma.(Phase II study)
Phase 2
Recruiting
- Conditions
- Hepatocellular carcinoma
- Registration Number
- JPRN-UMIN000013016
- Lead Sponsor
- Second department of surgery, Dokkyo Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients who have medical history of hypersensitivity of platinum-containing drug, iodine-containing drug and gelatine. 2) Patients with serious complications(Severe thyroid disease, Severe heart disease and the like.) 3) Patients with active double cancer. 4) Patients with bile duct invasion. 5) Pregnant and lactating females; males and females of childbearing age unless using effective contraception. 6) Patients without remarkable findings of A-V shunt and/or A-P shunt. 7) Tumor thrombosis in main portal vein or vena cava 8) Patients who are concluded to be inappropriate to participate in this study by their physicians
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method